Profile data is unavailable for this security.
About the company
United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.
- Revenue in USD (TTM)12.31m
- Net income in USD3.48m
- Incorporated1987
- Employees25.00
- LocationUnited-Guardian Inc230 Marcus BlvdHAUPPAUGE 11788-3731United StatesUSA
- Phone+1 (631) 273-0900
- Fax+1 (631) 273-0858
- Websitehttps://u-g.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp | 11.29m | -135.25m | 35.51m | 103.00 | -- | 0.3985 | -- | 3.14 | -52.81 | -52.81 | 0.6477 | 0.4768 | 0.0964 | 0.8291 | 4.05 | 109,621.40 | -115.46 | -59.46 | -134.34 | -65.92 | 20.74 | -- | -1,197.86 | -5,126.73 | 2.78 | -- | 0.0972 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -20.13m | 36.40m | 9.00 | -- | -- | -- | -- | -2.98 | -2.98 | 0.00 | -0.3049 | 0.00 | -- | -- | 0.00 | -307.64 | -149.95 | -- | -435.18 | -- | -- | -- | -- | -- | -378.19 | -- | -- | -- | -- | 43.61 | -- | -- | -- |
| Incannex Healthcare Inc | 86.00k | -23.15m | 36.87m | 9.00 | -- | 5.59 | -- | 428.76 | -1.40 | -1.40 | 0.0052 | 0.3738 | -- | -- | -- | 9,555.56 | -- | -130.12 | -- | -148.24 | -- | -- | -26,922.09 | -3,421.98 | -- | -- | 0.00 | -- | -- | 61.03 | 62.18 | -- | 73.79 | -- |
| Lexaria Bioscience Corp | 411.01k | -4.85m | 38.40m | 5.00 | -- | 3.44 | -- | 93.42 | -0.4455 | -0.4455 | 0.0408 | 0.6403 | 0.0539 | -- | 2.16 | 82,202.00 | -63.85 | -95.67 | -65.93 | -96.58 | 98.83 | 76.98 | -1,185.15 | -1,612.76 | -- | -64.96 | 0.00 | -- | -11.43 | -12.19 | 8.31 | -- | -- | -- |
| CEL-SCI Corp | 0.00 | -29.10m | 38.62m | 43.00 | -- | 4.02 | -- | -- | -0.5806 | -0.5806 | 0.00 | 0.1562 | 0.00 | -- | -- | -- | -100.88 | -70.19 | -124.78 | -78.31 | -- | -- | -- | -15,434.15 | 0.1793 | -36.79 | 0.5517 | -- | -- | -- | 13.99 | -- | 223.59 | -- |
| Verrica Pharmaceuticals Inc | 9.21m | -84.99m | 40.47m | 100.00 | -- | -- | -- | 4.39 | -1.83 | -1.83 | 0.1979 | -0.7467 | 0.1416 | 1.67 | 4.67 | 92,100.00 | -130.68 | -55.75 | -174.03 | -78.33 | 74.08 | -- | -922.81 | -754.94 | 1.22 | -10.16 | 3.82 | -- | -43.27 | -- | -173.59 | -- | 5.65 | -- |
| Fortress Biotech Inc | 62.50m | -57.53m | 43.27m | 186.00 | -- | 2.05 | -- | 0.6924 | -3.53 | -3.53 | 3.74 | 0.767 | 0.4502 | 2.16 | 6.70 | 336,026.90 | -88.98 | -52.50 | -142.15 | -99.46 | 60.55 | 63.17 | -197.64 | -236.94 | 1.06 | -9.66 | 1.31 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| United-Guardian, Inc. | 12.31m | 3.48m | 44.61m | 25.00 | 12.80 | 3.92 | 12.44 | 3.62 | 0.7585 | 0.7585 | 2.68 | 2.48 | 0.9684 | 4.74 | 7.44 | 492,490.80 | 27.41 | 29.84 | 31.57 | 34.39 | 53.43 | 55.31 | 28.30 | 28.79 | 6.02 | -- | 0.00 | 97.37 | -14.28 | -4.14 | 0.4616 | -9.92 | 17.19 | -19.73 |
| SCYNEXIS Inc | 8.57m | -36.44m | 44.78m | 29.00 | -- | 0.765 | -- | 5.23 | -0.756 | -0.756 | 0.177 | 1.54 | 0.0692 | -- | 3.61 | 295,379.30 | -29.44 | -30.02 | -35.54 | -36.35 | -71.42 | -- | -425.41 | -86.76 | -- | -- | 0.1843 | -- | 2,652.72 | 252.64 | 206.74 | -- | -- | -- |
| Earth Science Tech Inc | 26.89m | 2.33m | 48.58m | 32.00 | 21.08 | 15.18 | 19.60 | 1.81 | 0.0076 | 0.0076 | 0.0878 | 0.0105 | 6.65 | 23.99 | 201.60 | 840,435.90 | 57.64 | -37.98 | 79.28 | -- | 71.30 | 63.87 | 8.67 | -15.48 | 1.09 | 3.34 | 0.0241 | -- | 24,526.37 | 73.03 | 322.25 | -- | -- | -- |
| BGM Group Ltd | 29.87m | -7.86m | 49.10m | 298.00 | -- | 1.12 | -- | 1.64 | -1.10 | -1.10 | 4.18 | 6.07 | 0.5237 | 3.73 | 25.96 | 100,236.40 | -14.43 | 2.71 | -17.01 | 3.86 | 2.92 | 11.66 | -27.56 | 2.72 | 6.06 | -0.7527 | 0.00 | 26.11 | -28.35 | -1.60 | -822.64 | -- | 12.86 | -- |
| Odonate Inc | 0.00 | -102.07m | 49.87m | 137.00 | -- | 1,839.01 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| Immix Biopharma Inc | 0.00 | -21.89m | 49.96m | 14.00 | -- | 2.85 | -- | -- | -0.8536 | -0.8536 | 0.00 | 0.6387 | 0.00 | -- | -- | 0.00 | -92.58 | -- | -114.95 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
| Aadi Bioscience Inc | 25.07m | -61.69m | 54.72m | 53.00 | -- | 0.7935 | -- | 2.18 | -2.29 | -2.29 | 0.9285 | 2.80 | 0.2225 | 0.696 | 4.09 | 281,685.40 | -54.75 | -50.25 | -65.27 | -56.15 | 87.39 | -- | -246.06 | -473.97 | 4.54 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
Data as of Nov 21 2024. Currency figures normalised to United-Guardian Inc's reporting currency: US Dollar USD
18.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 30 Sep 2024 | 182.36k | 3.97% |
| GAMCO Asset Management, Inc.as of 30 Sep 2024 | 158.50k | 3.45% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 135.81k | 2.96% |
| Rodgers Brothers, Inc. (Investment Management)as of 30 Sep 2024 | 97.88k | 2.13% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 73.70k | 1.60% |
| Teton Advisors, Inc. (Investment Management)as of 30 Sep 2024 | 54.76k | 1.19% |
| Parthenon LLCas of 30 Sep 2024 | 51.91k | 1.13% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2024 | 48.23k | 1.05% |
| Gabelli Funds LLCas of 30 Sep 2024 | 38.00k | 0.83% |
| SBAuer Funds LLCas of 30 Sep 2024 | 30.00k | 0.65% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
